LORI WILSON: Open Payments
NPI 1235467994 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,882 in 127 payments from 22 companies in 2025. Trend: 2023 $2,076 · 2024 $2,873 · 2025 $2,882
Food & beverage: $2,882
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 38 | $899 |
| ABBVIE INC. | 20 | $417 |
| QOL Medical, LLC | 7 | $188 |
| Aimmune Therapeutics, Inc. | 12 | $173 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $155 |
| PFIZER INC. | 8 | $147 |
| Amgen Inc. | 1 | $108 |
| Madrigal Pharmaceuticals | 3 | $105 |
| Lilly USA, LLC | 5 | $95 |
| NeurAxis, Inc. | 1 | $86 |
Products named: TREMFYA, RINVOQ, Sucraid, VELSIPITY, VOWST, REZDIFFRA, ENTYVIO, DUPIXENT.
Industry payments across FL — which companies pay providers there.
